Review





Similar Products

91
ATCC smegmatis
Smegmatis, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smegmatis/product/ATCC
Average 91 stars, based on 1 article reviews
smegmatis - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

99
Worthington Biochemical dnase worthington ls002007 gentamycin sigma aldrich g1397 caution h317 334 glucose serva 22700 hbss gibco
Dnase Worthington Ls002007 Gentamycin Sigma Aldrich G1397 Caution H317 334 Glucose Serva 22700 Hbss Gibco, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dnase worthington ls002007 gentamycin sigma aldrich g1397 caution h317 334 glucose serva 22700 hbss gibco/product/Worthington Biochemical
Average 99 stars, based on 1 article reviews
dnase worthington ls002007 gentamycin sigma aldrich g1397 caution h317 334 glucose serva 22700 hbss gibco - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

93
Cayman Chemical 4anpp
4anpp, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4anpp/product/Cayman Chemical
Average 93 stars, based on 1 article reviews
4anpp - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
Thermo Fisher phosphorylated forms of ctni pierce ma1-22700
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
Phosphorylated Forms Of Ctni Pierce Ma1 22700, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phosphorylated forms of ctni pierce ma1-22700/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
phosphorylated forms of ctni pierce ma1-22700 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
PassMark Software Inc cpu mark 22700
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
Cpu Mark 22700, supplied by PassMark Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpu mark 22700/product/PassMark Software Inc
Average 90 stars, based on 1 article reviews
cpu mark 22700 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Rooibos Ltd green tea ean: 87 22700 05552 5
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
Green Tea Ean: 87 22700 05552 5, supplied by Rooibos Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/green tea ean: 87 22700 05552 5/product/Rooibos Ltd
Average 90 stars, based on 1 article reviews
green tea ean: 87 22700 05552 5 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

91
ATCC 57 y aaacag
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
57 Y Aaacag, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/57 y aaacag/product/ATCC
Average 91 stars, based on 1 article reviews
57 y aaacag - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

91
ATCC 51 y atcc
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
51 Y Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/51 y atcc/product/ATCC
Average 91 stars, based on 1 article reviews
51 y atcc - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

93
Cayman Chemical despropionylfentanyl
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
Despropionylfentanyl, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/despropionylfentanyl/product/Cayman Chemical
Average 93 stars, based on 1 article reviews
despropionylfentanyl - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

93
Cayman Chemical anilino n phenethylpiperidine
(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing <t>cTnI</t> phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P <t>represents</t> <t>non-phosphorylated</t> cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.
Anilino N Phenethylpiperidine, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anilino n phenethylpiperidine/product/Cayman Chemical
Average 93 stars, based on 1 article reviews
anilino n phenethylpiperidine - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

Image Search Results


(A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing cTnI phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P represents non-phosphorylated cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.

Journal: Journal of molecular and cellular cardiology

Article Title: Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes

doi: 10.1016/j.yjmcc.2020.10.006

Figure Lengend Snippet: (A-C) show myofilament Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation compared to donor tissue. (D-F) show Ca 2+ -sensitivity measured as EC 50 for the human samples HCM 173, HCM 175 and HCM 234 carrying the TNNT2 R278C mutation before and after normalizing cTnI phosphorylation by incubation with protein kinase A (PKA). (G) and (H) display the phosphorylation status of cardiac troponin I determined by phos-tag gel analysis before and after incubation with PKA. 0P represents non-phosphorylated cTnI, 1P single-phosphorylated cTnI and 2P double-phosphorylated cTnI. (G) shows the phos-tag gel image for the quantified data in (H). (I-K) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 compared to donor. (L-N) Length-dependent activation of the human samples HCM 173, HCM 175 and HCM 234 before and after PKA treatment. * p < 0.05, ** p < 0.01, unpaired t -test. n(Donor) = 4, n(HCM 173) = 4/3, n(HCM 175) = 4/3, R278C = 3/3 for with/without PKA, respectively.

Article Snippet: Non-, mono- and bis-phosphorylated forms of cTnI (Pierce, MA1-22700) were quantified by phos-tag gel analysis as described previously [ ].

Techniques: Mutagenesis, Phospho-proteomics, Incubation, Activation Assay